Mylan, Prosonix Use In Vitro Data To File Generic Fluticasone Inhaler In EU
This article was originally published in The Pink Sheet Daily
Executive Summary
Marketing submissions for generic inhaled respiratory products based on in vitro data alone may be less expensive and a quicker route to market than other EU regulatory processes for inhaled generics.